Burden of illness of diabetic macular edema: literature review

References

• American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern® Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008. Available at: http://www.aao.org/ppp [Last accessed 2 February 2010]
   Google Scholar
• King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
   PubMed Web of Science ®Google Scholar
• Diabetes Statistics. American Diabetes Association. Available at: http://www.diabetes.org/diabetes-statistics.jsp 2009. [Last accessed 2 February 2010]
   Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984;91:1464-74
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98:741-56
   PubMedGoogle Scholar
• Williams R, Airey M, Baxter H, et al. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 2004;18:963-83
   PubMed Web of Science ®Google Scholar
• Hirai FE, Knudtson MD, Klein BE, et al. Clinically significant macular edema and survival in type 1 and type 2 diabetes. Am J Ophthalmol 2008;145:700-6
   PubMed Web of Science ®Google Scholar
• Knudsen LL, Lervang HH, Lundbye-Christensen S, et al. The North Jutland County Diabetic Retinopathy Study: population characteristics. Br J Ophthalmol 2006;90:1404-9
   PubMed Web of Science ®Google Scholar
• Knudsen LL, Lervang HH, Lundbye-Christensen S, et al. The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema. Br J Ophthalmol 2007;91:1593-5
   PubMed Web of Science ®Google Scholar
• Broadbent DM, Scott JA, Vora JP, et al. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye 1999;13:160-5
   PubMed Web of Science ®Google Scholar
• Ling R, Ramsewak V, Taylor D, et al. Longitudinal study of a cohort of people with diabetes screened by the Exeter Diabetic Retinopathy Screening Programme. Eye 2002;16:140-5
   PubMed Web of Science ®Google Scholar
• Reuterving CO, Kratholm J, Wachtmeister L. Ophthalmic health care in diabetes mellitus: a cross-sectional study in northern Sweden. Ophthalmic Epidemiol 1999;6:267-78
   PubMedGoogle Scholar
• Romero-Aroca P, Fernandez-Alart J, Baget-Bernaldiz M, et al. Diabetic retinopathy epidemiology in type 2 diabetic patients. Effect of the changes in the diagnostic criteria and stricter control of the diabetes between 1993 and 2005 on the incidence of diabetic retinopathy. Arch Soc Esp Oftalmol 2007;82:209-18
   PubMedGoogle Scholar
• Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006;141:446-55
   PubMed Web of Science ®Google Scholar
• Blum M, Kloos C, Muller N, et al. Prevalence of diabetic retinopathy. Check-up program of a public health insurance company in Germany 2002-2004. Ophthalmologe 2007;104:499-500, 502-4
   PubMed Web of Science ®Google Scholar
• Klein R, Davis MD, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons. Adv Exp Med Biol 1985;189:321-35
   PubMed Web of Science ®Google Scholar
• Future sight loss in the decade 2010 to 2020: an epidemiological and economic model. Report prepared for RNIB by Darwin Minassian and Angela Reidy. July 2009. EpiVision. Available at: http://www.vision2020uk.org.uk/ukvisionstrategy/page.asp?section =74 [Last accessed 2 March 2010]
   Google Scholar
• West SK, Klein R, Rodriguez J, et al. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care 2001;24:1204-9
   PubMed Web of Science ®Google Scholar
• Varma R, Torres M, Pena F, et al. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology 2004;111:1298-1306
   PubMed Web of Science ®Google Scholar
• Roy MS, Klein R. Macular edema and retinal hard exudates in African Americans with type 1 diabetes: the New Jersey 725. Arch Ophthalmol 2001;119:251-9
   PubMed Web of Science ®Google Scholar
• Varma R, Klein R, West SK, et al. Are Latinos at greater risk for diabetic retinopathy than whites? Pooled findings from 3 population–based studies. Invest Ophthalmol Vis Sci 2005;46:1164
   Web of Science ®Google Scholar
• Flynn HW, Wong T, Mwamburi M, et al. Progression to proliferative diabetic retinopathy and severe visual impairment: a systematic review and meta-analysis [abstract]. Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting. May 3-7, Fort Lauderdale, FL
   Google Scholar
• Henricsson M, Sellman A, Tyrberg M, et al. Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study. Acta Ophthalmol Scand 1999;77:218-22
   PubMedGoogle Scholar
• Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009;116:497-503
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801-15
   PubMed Web of Science ®Google Scholar
• Klein R, Moss SE, Klein BE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989;96:1501-10
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. The Wisconsin epidemiologic study of diabetic retinopathy: an update. Aust N Z J Ophthalmol 1990;18:19-22
   PubMedGoogle Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7-16
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. How many steps of progression of diabetic retinopathy are meaningful? The Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 2001;119:547-553
   PubMed Web of Science ®Google Scholar
• Rossing K, Jacobsen P, Rossing P, et al. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care 1998;21:2007-15
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91:1-9
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994;101:1061-70
   PubMed Web of Science ®Google Scholar
• Klein R, Lee KE, Knudtson MD, et al. Changes in visual impairment prevalence by period of diagnosis of diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 2009;116:1937-42
   PubMed Web of Science ®Google Scholar
• Sjolie AK, Green A. Blindness in insulin-treated diabetic patients with age at onset less than 30 years. J Chronic Dis 1987;40:215-20
   PubMedGoogle Scholar
• Jeppesen P, Bek T. The occurrence and causes of registered blindness in diabetes patients in Arhus County, Denmark. Acta Ophthalmol Scand 2004;82:526-30
   PubMedGoogle Scholar
• Grauslund J, Green A, Sjolie AK. Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patients. Ophthalmology 2009;116:2170-4
   PubMed Web of Science ®Google Scholar
• Shea AM, Curtis LH, Hammill BG, et al. Resource use and costs associated with diabetic macular edema in elderly persons. Arch Ophthalmol 2008;126:1748-54
   PubMed Web of Science ®Google Scholar
• Lee LJ, Yu AP, Cahill KE, et al. Direct and indirect costs among employees with diabetic retinopathy in the United States. Curr Med Res Opin 2008;24:1549-59
   PubMed Web of Science ®Google Scholar
• Happich M, Reitberger U, Breitscheidel L, et al. The economic burden of diabetic retinopathy in Germany in 2002. Graefes Arch Clin Exp Ophthalmol 2008;246:151-9
   PubMed Web of Science ®Google Scholar
• Javitt JC, Aiello LP, Bassi LJ, et al. Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology. Ophthalmology 1991;98:1565-73
   PubMed Web of Science ®Google Scholar
• Huang ES, Brown SE, Ewigman BG, et al. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007;30:2478-83
   PubMed Web of Science ®Google Scholar
• Lee DJ, Gomez-Marin O, Lam BL, et al. Visual impairment and morbidity in community-residing adults: the national health interview survey 1986-1996. Ophthalmic Epidemiol 2005;12:13-17
   PubMed Web of Science ®Google Scholar
• Varma R, Wu J, Chong K, et al. Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 2006;113:1846-53
   PubMed Web of Science ®Google Scholar
• Hariprasad SM, Mieler WF, Grassi M, et al. Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol 2008;92:89-92
   PubMed Web of Science ®Google Scholar
• Davidov E, Breitscheidel L, Clouth J, et al. Diabetic retinopathy and health-related quality of life. Graefes Arch Clin Exp Ophthalmol 2009;247:267-72
   PubMed Web of Science ®Google Scholar
• Tranos PG, Topouzis F, Stangos NT, et al. Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life. Curr Eye Res 2004;29:41-9
   PubMed Web of Science ®Google Scholar